Editorial: Are natural products, used as antitumoral/antiangiogenic agents, less toxic than synthetic conventional chemotherapy?
Front Pharmacol
.
2022 Oct 21:13:1055516.
doi: 10.3389/fphar.2022.1055516.
eCollection 2022.
Authors
Cecilia Veronica Nunez
1
,
Marne Carvalho de Vasconcellos
2
,
Laura Alaniz
3
Affiliations
1
Bioprospection and Biotechnology Laboratory, National Institute of Amazonian Research (INPA), Manaus, Brazil.
2
Faculty of Pharmaceutical Sciences, Federal University of Amazonas (UFAM), Manaus, Brazil.
3
CIBA, Northwest Research and Transfer Center of the Province of Buenos Aires (UNNOBA), CIT NOBA (UNNOBA-UNSAdA-CONICET), Junin, Bs.As., Argentina.
PMID:
36339558
PMCID:
PMC9634553
DOI:
10.3389/fphar.2022.1055516
No abstract available
Keywords:
antiangiogenic; antitumoral; mechanisms of action; natural products; new drugs.
Publication types
Editorial